Beaverton, OR — October 20, 2025 – Novogene, your trusted multi-omics partner, proudly celebrates the grand opening of its new state-of-the-art laboratory in Beaverton, Oregon. This milestone marks a significant step in Novogene’s strategic expansion across North America and reinforces its commitment to advancing genomic research and innovation.

The event welcomes Zong Ye Wu (Lab Director), Douglas Zhang (VP of Novogene America), Justin Lee (VP of NovogeneAIT), along with District Directors from U.S. sales—highlighting the company’s leadership in genomic innovation.

Also in attendance are representatives from top academic and industry institutions, including OHSU, Stanford, UC Berkeley, UC San Diego, and Illumina, as well as Beaverton Mayor Lacey Beaty, whose presence highlighted the city’s support for scientific innovation and local economic growth. Their participation reflectes Novogene’s strong partnerships and commitment to collaborative research across the life sciences community.

The grand opening is commenced with remarks from Vice President Douglas Zhang, followed by a ribbon-cutting ceremony led by Novogene executives and Illumina representatives. Guests tour the new facility, gaining a firsthand look at its advanced sequencing capabilities. The day is also feeatured with industry networking events, offering a relaxed setting for meaningful conversations and collaboration.

We are thrilled to open our Beaverton lab and welcome our partners and clients to see firsthand the innovation and dedication that drives Novogene,” said Douglas Zhang, VP of Novogene America. “This facility represents our continued investment in supporting cutting-edge research and delivering high-quality genomic services.

The Beaverton lab will serve the whole America Territories for Novogene’s operations, enhancing service capabilities and turnaround times for clients in both North and South America.